ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,161.46
0.66%
Dow Jones
38,756.12
0.21%
US Dollar vs MXN
16.88542
-0.58%
Brent Oil
83.135
0.01%
Bitcoin
63,181.31
-1.28%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. VBI Vaccines Inc (VBIV)

  7. VBI Vaccines Inc (VBIV) Noticias

VBIV VBI Vaccines Inc

0.5805
-0.0095 (-1.61%)
Última actualización: 11:38:47
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
VBI Vaccines Inc VBIV NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0095 -1.61% 0.5805 11:38:47
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.585 0.576465 0.59 0.59
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202407:00BWVBI Vaccines Reports Full Year 2023 Financial Results
11/4/202415:05BWVBI Vaccines Announces Closing of $2 Million Registered..
09/4/202413:45BWVBI Vaccines Announces $2 Million Registered Direct Offering..
03/4/202407:00BWVBI Vaccines Presents Encouraging Early Tumor Response Data..
02/4/202407:00BWVBI Vaccines Announces Expanded Strategic Partnership with..
14/2/202407:34EDGAR2Form 8-K - Current report
14/2/202406:00BWVBI Announces Agreement to Sell Manufacturing Capabilities,..
06/2/202415:23EDGAR2Form 8-K - Current report
23/1/202415:15EDGAR2Form 8-K - Current report
11/1/202415:15EDGAR2Form 8-K - Current report
26/12/202315:15EDGAR2Form 8-K - Current report
12/12/202315:15EDGAR2Form 8-K - Current report
29/11/202315:15EDGAR2Form 8-K - Current report
20/11/202307:00EDGAR2Form 8-K - Current report
20/11/202307:00BWVBI Vaccines Presents Additional Biomarker Data from Phase..
14/11/202315:07EDGAR2Form 8-K - Current report
14/11/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202315:05BWVBI Vaccines Reports Third Quarter 2023 Financial Results
03/11/202316:00EDGAR2Form 8-K - Current report
26/10/202307:00EDGAR2Form 8-K - Current report
26/10/202307:00BWVBI Vaccines Expands Proprietary Technology Platforms With..
27/9/202306:30EDGAR2Form 8-K - Current report
27/9/202306:30BWVBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901,..
07/9/202307:00EDGAR2Form 8-K - Current report
07/9/202307:00BWVBI Vaccines Announces Dosing of First Patients in Phase 2b..
06/9/202308:12EDGAR2Form 8-K - Current report
06/9/202307:00BWVBI Vaccines Partner Brii Biosciences Announces Topline..
14/8/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202307:00EDGAR2Form 8-K - Current report
14/8/202307:00BWVBI Vaccines Reports Second Quarter 2023 Financial Results
31/7/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202315:05EDGAR2Form 8-K/A - Current report: [Amend]
24/7/202307:00EDGAR2Form 8-K - Current report
24/7/202307:00BW VBI Vaccines Announces Closing of Underwriters’ Partial..
20/7/202315:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/7/202307:00EDGAR2Form 8-K - Current report
19/7/202307:00BWVBI Vaccines Announces PreHevbri® is Now Available in the..
18/7/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202315:05EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
VBIV
VBI Vaccines
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados